Home / Congress Presentations / Geographic Atrophy / Association for Research in Vision & Ophthalmology (ARVO) 2023
Landing
Association for Research in Vision & Ophthalmology (ARVO) 2023
Disease activity of geographic atrophy in fellow eyes of the pegcetacoplan phase III trials measured by automated AI-based OCT biomarker quantifications
Access Resources
Assessment of geographic atrophy (GA) progression in the phase 3 OAKS and DERBY trials
Prevalence of Outer Retinal Tubulation (ORT) and Association with Geographic Atrophy (GA) Lesion Growth Among GA Patients in the FILLY Trial
Inter-reader variability of geographic atrophy (GA) lesion measurements on fundus autofluorescence (FAF) in the Phase III OAKS and DERBY trials of pegcetacoplan for the treatment of GA secondary to age-related macular degeneration
The MOSAIC Study: A clinical and humanistic burden of illness study among patients with geographic atrophy (GA) and their caregivers in the United States (US) and Canada (CA)
Therapeutic effect of pegcetacoplan on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity in geographic atrophy (GA) in the phase III OAKS and DERBY trials
Comparison of Artificial Intelligence-based OCT and manual Fundus Autofluorescence measurements of Geographic Atrophy in the phase III OAKS/DERBY trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.